Redwood Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Redwood Investment Management's BMY Position: Q1 2026 in Review
Redwood Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 14% in Q1 2026, selling an estimated $132K and leaving 14,098 shares worth $855K. The position accounts for 0.11% of the portfolio, ranked #178.
Redwood Investment Management first reported a position in BMY in Q2 2019 and has held it in 18 quarters since. The position peaked at $7.82M in Q1 2024. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Redwood Investment Management held 14,098 shares of Bristol-Myers Squibb worth $855K as of Q1 2026.
- Redwood Investment Management sold 2,260 Bristol-Myers Squibb shares in Q1 2026, an estimated $132K.
- Bristol-Myers Squibb made up 0.11% of Redwood Investment Management's portfolio in Q1 2026, its #178 holding.
- Redwood Investment Management first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 18 quarters since.
- Redwood Investment Management's Bristol-Myers Squibb position peaked at $7.82M in Q1 2024.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Redwood Investment Management's 13F filing for Q1 2026, filed 14 May 2026.